These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9972766)

  • 21. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD; Picker MJ
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
    Allen RM; Granger AL; Dykstra LA
    J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Zhang L; Walker EA; Sutherland J; Young AM
    Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
    Walker EA; Young AM
    Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A; Morse WH; Bergman J
    J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
    Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor.
    Morgan D; Picker MJ
    Behav Pharmacol; 1996 May; 7(3):261-284. PubMed ID: 11224419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic exercise decreases sensitivity to mu opioids in female rats: correlation with exercise output.
    Smith MA; Lyle MA
    Pharmacol Biochem Behav; 2006 Sep; 85(1):12-22. PubMed ID: 16904173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
    Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
    Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
    Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
    Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine-like discriminative stimulus effects and [3H]dopamine uptake inhibition produced by selected partial opioid agonists.
    Barrett AC; Morgan D; Izenwasser S; Picker MJ
    Behav Pharmacol; 2001 Jul; 12(4):225-35. PubMed ID: 11548108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.